Unknown

Dataset Information

0

Human organ rejuvenation by VEGF-A: Lessons from the skin.


ABSTRACT: Transplanting aged human skin onto young SCID/beige mice morphologically rejuvenates the xenotransplants. This is accompanied by angiogenesis, epidermal repigmentation, and substantial improvements in key aging-associated biomarkers, including ß-galactosidase, p16ink4a, SIRT1, PGC1α, collagen 17A, and MMP1. Angiogenesis- and hypoxia-related pathways, namely, vascular endothelial growth factor A (VEGF-A) and HIF1A, are most up-regulated in rejuvenated human skin. This rejuvenation cascade, which can be prevented by VEGF-A-neutralizing antibodies, appears to be initiated by murine VEGF-A, which then up-regulates VEGF-A expression/secretion within aged human skin. While intradermally injected VEGF-loaded nanoparticles suffice to induce a molecular rejuvenation signature in aged human skin on old mice, VEGF-A treatment improves key aging parameters also in isolated, organ-cultured aged human skin, i.e., in the absence of functional skin vasculature, neural, or murine host inputs. This identifies VEGF-A as the first pharmacologically pliable master pathway for human organ rejuvenation in vivo and demonstrates the potential of our humanized mouse model for clinically relevant aging research.

SUBMITTER: Keren A 

PROVIDER: S-EPMC9232104 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10579575 | biostudies-literature
| S-EPMC7118506 | biostudies-literature
2024-11-18 | GSE274955 | GEO
| S-EPMC8629261 | biostudies-literature
| S-EPMC4428072 | biostudies-literature
| S-EPMC6205340 | biostudies-literature
| S-EPMC3547222 | biostudies-literature
| PRJNA1148640 | ENA
| S-EPMC7086200 | biostudies-literature
| S-EPMC6941387 | biostudies-literature